The proposed investigations extend the applicant's research program directed at elucidating the etiology of substance use disorder (SUD). Utilizing almost 25 years of already collected longitudinal data and data to be collected during the next several years in this ongoing NIDA-funded Center for Education and Drug Abuse Research (CEDAR), analyses will be directed at joining individual vulnerability (particularly neurobehavior disinhibition, ND) and multiple facets of the environment to model the pathway(s) to SUD between ages 10-25. Neurobehavior disinhibition (encompassing the cognitive, affect and behavior components of psychological dysregulation) has been shown in 12 published reports I: i) have excellent psychometric properties (including predictive validity);ii) be informative for modeling SUD etiology in a developmental framework;iii) define a very high risk subset of 10-12 year olds having .95 probability of developing SUD;iv) correlate with electrophysiological and neuroimaging variables reflecting prefrontal cortex dysfunction;and, v) mediate adverse family, peer and neighborhood influences on SUD risk. This award will enable me to reallocate many of my day-to-day responsibilities while retaining leadership as the Center's PI. This award will provide me protected time for research integrating over two decades of accrued data for comprehensive analysis. This research is thematically guided, empirically grounded, and innovative in at least five ways: i) it captures SUD vulnerability integrating cognition, emotion, and behavior;ii) it integratively incorporates diverse age- appropriate environment influences;ii) it provides the opportunity to determine if there is differential salience of the various component of individual vulnerability and environment across the main age span of SUD development;iv) it is the first attempt to determine whether a composite index depicting a specific """"""""environtype"""""""" at each age predisposes to SUD;and, v) employs item response theory (IRT) methods to quantify SUD severity taking into account all current and lifetime comorbid patterns in a mathematically accurate fashion, thereby enabling delineation of the covariation between severity of ND vulnerability and severity of SUD outcome. The proposed research aligns with the applicant's efforts in science advocacy pertaining to SUD etiology and prevention. By developing gender, ethnicity and age-appropriate algorithms for quantifying risk for SUD at the individual level withi a developmental framework, the NIH Roadmap framework will be advanced. Specifically, prevention can be designed that is empirically connected to the person's vulnerability and environment contexts. Hence, as a founding member of the Society of Prevention Research (SPR) and a member on the Board of the International Network of Patient-Centered Medicine (INPCM), a long-term career goal is to apply empirical research on SUD etiology for prevention practice.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Scientist Award (K05)
Project #
Application #
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Weinberg, Naimah Z
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Pharmacy
United States
Zip Code
Marceau, Kristine; Kirisci, Levent; Tarter, Ralph E (2018) Correspondence of Pubertal Neuroendocrine and Tanner Stage Changes in Boys and Associations With Substance Use. Child Dev :
Cochran, Gerald T; Hruschak, Valerie; Abdullah, Walitta et al. (2018) Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study. J Addict Med 12:72-79
Cochran, Gerald; McCarthy, Rebecca; Gordon, Adam J et al. (2017) Opioid medication misuse among unhealthy drinkers. Drug Alcohol Depend 179:13-17
Cochran, Gerald; Hruschak, Valerie; Bacci, Jennifer L et al. (2017) Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis. Res Social Adm Pharm 13:1055-1061
Cochran, Gerald T; Engel, Rafael J; Hruschak, Valerie J et al. (2017) Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research. J Pharm Pract 30:498-505
Cochran, Gerald; Bacci, Jennifer L; Ylioja, Thomas et al. (2016) Prescription opioid use: Patient characteristics and misuse in community pharmacy. J Am Pharm Assoc (2003) 56:248-256.e6
Cochran, Gerald; Gordon, Adam J; Field, Craig et al. (2016) Developing a framework of care for opioid medication misuse in community pharmacy. Res Social Adm Pharm 12:293-301
Gathuru, Irene M; Tarter, Ralph E; Klein-Fedyshin, Michele (2015) Review of hookah tobacco smoking among college students: policy implications and research recommendations. Am J Drug Alcohol Abuse 41:272-80
Cochran, Gerald; Rubinstein, Jessica; Bacci, Jennifer L et al. (2015) Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse. J Addict Med 9:411-6
Cornelius, Jack R; Kirisci, Levent; Reynolds, Maureen et al. (2015) Does the Transmissible Liability Index (TLI) assessed in late childhood predict suicidal symptoms at young adulthood? Am J Drug Alcohol Abuse 41:264-8

Showing the most recent 10 out of 25 publications